SUMMARY FIGURETOTAL GLOBAL MARKET SIZE AND GROWTH FOR CORONARY STENT DEVICES BY REGION, 2010-2016($ MILLIONS)
Source: BCC Research
INTRODUCTION
STUDY GOALS AND OBJECTIVES
The objectives of the study are to present a comprehensive look at coronary stents for treating cardiovascular disease, to examine global market measurements of both the overall market and all possible market segments, and to forecast market and segment growth over the next five years.
REASONS FOR STUDY
This BCC study is presented to increase the awareness of coronary stent devices used to treat cardiovascular disease. The study analyzes select coronary stent devices for treating various cardiac diseases such as coronary artery disease, peripheral vascular disease, valvular heart disease, congestive heart failure and many others; understanding the global market from different standpoints; and addressing issues and trends affecting the market. Coronary stent device manufacturers, driven by both research breakthroughs and increased recognition of expanding market opportunities, have stepped up the pace of development of innovative products. Because of the evolving nature of this important area of study, executives of product development for coronary stent devices must remain ever vigilant of the changing environment and strive to keep abreast of new and currently used modalities in all facets of the market.
SCOPE OF STUDY
This report is a comprehensive business tool designed to provide an in-depth look at coronary stent devices for various cardiovascular applications. The geographic scope of the report is global with special emphasis on individual regions. The report describes the industry, its relationship to the healthcare industry and its participants, and trends for the future.
Categories discussed in the report include:
Technologies discussed in the report include:
All categories are discussed in detail, describing each segment, identifying current products on the market, measuring market size, identifying market drivers, forecasting for 2011 to 2016 and assessing the competitors and competitor market shares.
METHODOLOGY AND INFORMATION SOURCES
The information and analysis presented in this BCC report are based on extensive first-hand interviews with primary research sources, including executives, product managers, and clinical specialists in the congestive heart failure drug development arena. Background information was obtained from various government agencies, business and medical journals, trade magazines, and interviews with doctors and nurses involved in the treatment of congestive heart failure.
Key information from published literature was used to conduct interviews with over 20 industry participants to validate and obtain expert opinions on current and future trends in the coronary stent market. Interviews were the primary basis for development of market size. Interviews were also used to confirm and/or adjust market size and market share estimates, as well as in formulating market projections.
All market data pertain to the global market at the manufacturer’s level. Data are expressed in current U.S. dollars. The base year was 2011. Historical data are provided for 2010 and forecast data are provided for 2016. Historical, base year and forecast data are provided for each market segment and subsegment. Market shares are provided for each market segment for the 2011 base year.
ANALYST CREDENTIALS
Mary Anne Crandall is an expert industry analyst specializing in the medical pharmaceutical and device industry for the last 20 years. She has completed several in-depth studies on various medical topics requiring both medical expertise and excellent knowledge of the pharmaceutical and medical device industries. Ms. Crandall has extensive knowledge in the medical field, has a M.S. in psychology and is currently working on a Ph.D.
BCC ON-LINE SERVICES
BCC Research offers an online information retrieval service. Its home page, located at www.bccresearch.com, enables readers to:
DISCLAIMER
This publication provides informative material of a professional nature. It does not constitute managerial, legal, or accounting advice, nor should it serve as a corporate policy guide or an endorsement of any given product or company. This information is intended to be as accurate as possible at the time it was written and was undertaken on a best-effort basis. The views expressed are those of the author and do not make any warranty, express or implied, for the accuracy, completeness, or usefulness of the information, or for the interpretation of data or its use by others. Projections involve risks and uncertainties that include but are not limited to technical risks associated with technology development, government regulatory approvals, and access to capital. The author assumes no responsibility for any losses or damages that may result from one’s reliance on this material.
